PLK1 and neoplasm: Moreover, we demonstrated for the first time that iNOP-7 could deliver clinically-relevant amounts of PLK1 siRNA to lung tumors and reduce their proliferation in an orthotopic NSCLC mouse model which closely mimics the tumor microenvironment observed in the clinical setting.